PSC
RLM

Piper Sandler & Co’s Realm Therapeutics plc American Depositary Shares RLM Stock Holding History

Piper Sandler & Co’s Portfolio RLM Stock Details RLM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-611
Closed -$2K – 34
2019
Q2 		$2K Buy
+611
New +$2.02K ﹤0.01% 17

Piper Sandler & Co's RLM Position: Q3 2019 in Review

Piper Sandler & Co sold out of Realm Therapeutics plc American Depositary Shares (RLM) in Q3 2019, closing a stake of 611 shares — an estimated $2K sold.

Piper Sandler & Co first reported a position in RLM in Q2 2019 and held it in 1 quarter. The position peaked at $2K in Q2 2019. 0 funds tracked by Wall St. Rank hold RLM as of Q3 2019.

  • Piper Sandler & Co reported no remaining Realm Therapeutics plc American Depositary Shares position as of Q3 2019 after selling out during the quarter.
  • Piper Sandler & Co sold 611 Realm Therapeutics plc American Depositary Shares shares in Q3 2019, an estimated $2K.
  • Piper Sandler & Co first reported a position in Realm Therapeutics plc American Depositary Shares in Q2 2019 and held it in 1 quarter.
  • Piper Sandler & Co's Realm Therapeutics plc American Depositary Shares position peaked at $2K in Q2 2019.
  • 0 funds tracked by Wall St. Rank held Realm Therapeutics plc American Depositary Shares as of Q3 2019.

Based on Piper Sandler & Co's 13F filing for Q3 2019, filed 14 Nov 2019.